Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 3

1(16.7%)

Phase 4

1(16.7%)

6Total

N/A(4)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06653569Phase 3Recruiting

Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)

Role: collaborator

NCT07407387Not ApplicableNot Yet Recruiting

Ensuring Clinical Appropriateness and Safety of Pharmacological Therapies in Nursing Home Residents

Role: collaborator

NCT06331130Recruiting

Mesenteric Infiltration in Ovarian Cancer

Role: collaborator

NCT04214210Not ApplicableRecruiting

The DIALOGUE Study: Swiss-Korean Billateral Collaboration

Role: collaborator

NCT05797324Not ApplicableUnknown

Light Therapy in Modulating the Clinical Phenotype of Patients With Primary and Comorbid Chronic Insomnia.

Role: collaborator

NCT03120975Not ApplicableCompleted

Computerized Antibiotic Stewardship Study

Role: collaborator

NCT01411514Phase 4Terminated

Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis

Role: collaborator

All 7 trials loaded